Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New appointment at Third Rock Ventures

This article was originally published in Scrip

Executive Summary

Third Rock Ventures, a US-based venture capital firm focused on launching life sciences companies, has appointed Dr Steven Paul venture partner. He leads the Helen & Robert Appel Institute for Alzheimer's Research at Weill Cornell Medical College and is the former president of the Lilly Research Laboratories. In his role as venture partner, Dr Paul will serve as a senior advisor to Third Rock and will participate in the development of potential new companies.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC010415

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel